Key result
Targeting mitochondrial dynamics shows potential to mitigate aging-related cardio-cerebrovascular disease.
Why the study?
Impaired mitochondrial fusion and fission contribute to the pathophysiology of aging-related cardio-cerebral diseases, and targeting these processes may offer new treatment strategies.
Targeting mitochondrial dynamics through exercise or pharmacological agents like metformin and dapagliflozin offers potential new therapeutic strategies for age-related cardio-cerebral diseases.
Mitochondria play a crucial role in cellular energy metabolism. The heart and brain require a continuous and stable energy supply. Energy production strongly depends on proper mitochondrial function. Mitochondrial fusion and fission, known as "plasticity", are vital for maintaining the normal physiological function of cells. Recent studies have shown that impaired mitochondrial dynamics are present in many aging-related diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and atherosclerotic cardio-cerebrovascular disease. The role of impaired mitochondrial dynamics in the pathophysiological process of aging-related diseases is being actively researched. We discovered that targeting proteins related to mitochondrial dynamics, especially those involved in fission and fusion, may offer new treatment strategies for these diseases. Various approaches, including aerobic interval and treadmill training and the use of drugs such as the antidiabetic agents metformin and dapagliflozin, the antihypertensive agent irbesartan, and certain traditional Chinese medicine components, have shown potential in alleviating imbalances in mitochondrial dynamics in aging-related cardio-cerebrovascular diseases. In this review, we systematically summarize recent research on alterations in mitochondrial dynamics in age-related cardio-cerebral diseases and explore therapeutic strategies targeting these alterations, which may offer new directions for improving cardiac and brain health and guiding clinical practice.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) conducted a review in Age-related cardio-cerebral diseases. Targeting mitochondrial dynamics (e.g., aerobic training, metformin, dapagliflozin, irbesartan) was evaluated. Targeting mitochondrial dynamics through exercise, antidiabetic agents, and antihypertensives shows potential in alleviating imbalances in aging-related cardio-cerebrovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: